Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Randomized, Double-blind Trial of BMF-219 Compared to Placebo in Participants With Type 1 Diabetes Mellitus

NCT06152042 is registered in ClinicalTrials.gov with Biomea Fusion Inc. as lead sponsor.

NCT NCT06152042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06152042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Randomized, Double-blind Trial of BMF-219 Compared to Placebo in Participants With Type 1 Diabetes Mellitus
Lead sponsor
Biomea Fusion Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 28, 2023
Completion date
July 18, 2025
Enrollment
37 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus